Page 2 - Ann Burrell News Today

Judith Burrell passed away. This is the full obituary where you can share condolences and memories. Published in the Cumberland Times News on 2023-11-15.

A Dunfermline shop has launched a new eco-friendly living range.

Clarius Group LLC raised its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 115.6% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 60,615 shares of the company’s stock after purchasing an additional 32,504 shares during the quarter. Clarius Group […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the twelve research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price […]

Nikko Asset Management Americas Inc. boosted its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 31.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 673,690 shares of the company’s stock after acquiring an additional 162,759 shares during the period. […]

Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its price target reduced by Royal Bank of Canada from $50.00 to $42.00 in a research note issued to investors on Thursday morning, The Fly reports. A number of other analysts have also commented on the company. Sanford C. Bernstein initiated coverage on Beam Therapeutics in a report […]

Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its target price decreased by Barclays from $45.00 to $41.00 in a report released on Thursday morning, The Fly reports. Several other research analysts have also commented on the company. William Blair restated an outperform rating on shares of Beam Therapeutics in a research report on Wednesday, March […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 12,870,000 shares, a decline of 5.4% from the March 31st total of 13,610,000 shares. Based on an average daily volume of 931,200 shares, the days-to-cover ratio is presently 13.8 days. […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among […]